First Symptoms and Neurocognitive Correlates of Behavioral Variant Frontotemporal Dementia.

J Alzheimers Dis

Laboratory of Experimental Psychology and Neuroscience (LPEN), Institute of Translational and Cognitive Neuroscience (INCyT), INECO Foundation, Favaloro University, Buenos Aires, Argentina.

Published: October 2016

AI Article Synopsis

  • The study investigates how the initial symptoms of apathy or disinhibition in patients with behavioral variant frontotemporal dementia (bvFTD) relate to their neurocognitive decline over time.
  • Researchers compared healthy individuals with bvFTD patients exhibiting one of the two symptoms to identify brain atrophy and cognitive differences linked to each presentation.
  • Findings suggest that the first symptom can predict future cognitive impairments and may aid in early detection and treatment strategies for bvFTD.

Article Abstract

Background: Previous works highlight the neurocognitive differences between apathetic and disinhibited clinical presentations of the behavioral variant frontotemporal dementia (bvFTD). However, little is known regarding how the early presentation (i.e., first symptom) is associated to the neurocognitive correlates of the disease's clinical presentation at future stages of disease.

Objectives: We analyzed the neurocognitive correlates of patients with bvFTD who debuted with apathy or disinhibition as first symptom of disease.

Methods: We evaluated the neuropsychological, clinical, and neuroanatomical (3T structural images) correlates in a group of healthy controls (n = 30) and two groups of bvFTD patients (presented with apathy [AbvFTD, n = 18] or disinhibition [DbvFTD, n = 16]). To differentiate groups according to first symptoms, we used multivariate analyses.

Results: The first symptom in patients described the evolution of the disease. AbvFTD and DbvFTD patients showed increased brain atrophy and increased levels of disinhibition and apathy, respectively. Whole brain analyzes in AbvFTD revealed atrophy in the frontal, insular, and temporal areas. DbvFTD, in turn, presented atrophy in the prefrontal regions, temporoparietal junction, insula, and temporoparietal region. Increased atrophy in DbvFTD patients (compared to AbvFTD) was observed in frontotemporal regions. Multivariate analyses confirmed that a set of brain areas including right orbitofrontal, right dorsolateral prefrontal, and left caudate were enough to distinguish the patients' subgroups.∥Conclusion: First symptom in bvFTD patients described the neurocognitive impairments after around three years of disease, playing an important role in the early detection, disease tracking, and neuroanatomical specification of bvFTD, as well as in future research on potential disease-modifying treatments.

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-160501DOI Listing

Publication Analysis

Top Keywords

neurocognitive correlates
12
behavioral variant
8
variant frontotemporal
8
frontotemporal dementia
8
bvftd patients
8
patients described
8
dbvftd patients
8
patients
6
bvftd
5
symptoms neurocognitive
4

Similar Publications

Background: Cardiovascular diseases such as coronary artery disease (CAD) have a high prevalence of psychiatric comorbidities, that may impact clinically relevant outcomes (e.g., cognitive impairment and executive dysfunction).

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.

Background: Thalassemia is a hereditary disease with impaired red blood cell production, resulting in cumulative systemic iron burden. The life-long therapeutic blood transfusion with or without iron chelators in those patients leads to the development of early-onset neurocognitive decline. However, the effects of regularity of blood transfusion on the severity of iron burden, cognitive decline, and gut dysbiosis in thalassemia patients are still unclear.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Neurocognitive Unit, Division of Neurology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Background: Episodic memory change is among the earliest symptoms of Alzheimer's disease (AD). Accumulation of neurofibrillary tangles in limbic regions serves as a key indicator of the initial tau abnormality. This study aimed to investigate the correlations between episodic memory change and quantitative tau deposition specifically in Braak stage 3-4 Limbic regions among participants with mild cognitive impairment (MCI) and mild dementia.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Universidad Simón Bolívar, Barranquilla, Colombia.

Background: The neuropsychological profile within indigenous communities is a complex interplay of cultural, social, and environmental factors that significantly influence cognitive functioning and distinct neuropsychological patterns. The aim of this study was to assess the neuropsychological profile in the Wayuu indigenous population.

Methods: A cross-sectional study.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

University of Athens, Athens, Greece.

Background: Cognitive deficits may occur in about 60% of patients with multiple sclerosis (MS) and executive functions, working memory and new-learning are commonly impaired. Nevertheless, there is limited research regarding decisional capacity in MS. Financial and treatment-decision capacity are complex activities of daily living.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!